between the role of incoming, capsid-associated and newly synthesized µ1, we used siRNA-23 mediated knockdown. Loss of newly synthesized µ1 protein does not impact apoptotic cell death 24 in HeLa cells but enhances necroptosis in L929 cells. Knockdown of µ1 also impacts aspects of 25 viral replication. We found that while µ1 knockdown results in diminished release of infectious 26 viral progeny from infected cells, viral minus strand RNA, plus strand RNA, and proteins that are 27 not targeted by the µ1 siRNA accumulate to a greater extent when compared to control siRNA-28 treated cells. Furthermore, we observe a decrease in sensitivity of these viral products to 29 inhibition by GuHCl (which targets minus strand synthesis to produce dsRNA) when µ1 is 30 knocked down. Following µ1 knockdown, cell death is also less sensitive to treatment with 31
GuHCl. Our studies suggest that the absence of µ1 allows enhanced transcriptional activity of 32 newly synthesized cores and the consequent accumulation of viral gene products. We speculate 33 that enhanced accumulation and detection of these gene products due to a µ1 knockdown 34 potentiates RIP3 dependent cell death. 35
IMPORTANCE 36
We use mammalian reovirus as a model to study how virus infections result in cell death. Here, 37
we sought to determine how viral factors regulate cell death. Our work highlights a previously 38 unknown role for reovirus outer capsid protein µ1 in limiting the induction of a necrotic form of 39 cell death called necroptosis. Induction of cell death by necroptosis requires the detection of 40 viral gene products late in infection. µ1 limits cell death by this mechanism because it prevents 41 excessive accumulation of viral gene products that trigger cell death. Replication of a virus within host cells can result in cell death (1), which is often detrimental to virus infection (2). To counter the antiviral effect of cell death, many viruses encode proteins 48 which prevent cell death (1, 2). In some cases, cell death can have pathogenic consequences. 49
In instances where cell death is required for cell-to-cell spread of the virus or dissemination of 50 virus beyond the primary site of replication, cell death can exacerbate disease (1). Additionally, 51 tissue injury caused by cell death can also contribute to viral disease. Mammalian reovirus has 52 been used as an experimental model to investigate the impact of cell death on viral disease. In 53 a mouse model of infection, the potential for reovirus to cause heart or CNS disease is 54 dependent on its capacity to induce cell death by apoptosis (3-5). Numerous studies have 55 mapped out both viral and cellular factors that influence apoptosis induction and disease 56 following reovirus infection. 57
The known viral determinants of reovirus-induced apoptosis are the attachment protein 58 σ1 and the membrane penetration protein µ1 (6-9). The role of σ1 in controlling cell death 59 correlates with the efficiency with which σ1 mediates attachment to host cell receptors (8, 9) . 60
The reovirus outer-capsid protein µ1, which plays an essential role in delivering the viral core 61 particle into the cytoplasm, is also important for controlling the efficiency with which reovirus 62 induces apoptosis. Mutations within the C-terminal region of µ1 diminish the capacity of reovirus 63 to evoke proapoptotic signaling (10, 11). Cell death signaling following ectopic expression of µ1 64 in plasmid transfected cells also supports this idea (12, 13) . Even in this artificial context, the C-65 terminal region of µ1, which affects the localization of µ1 to intracellular membranous structures 66 such as mitochondria, plays an important role in release of proapoptotic factors cytochrome c 67 and smac/DIABLO from the mitochondria and activation of effector caspases (12, 13) . Based on 68 the evidence that events that occur prior to viral gene expression are sufficient for the induction of apoptosis (9, 14) , it is assumed that the effect of µ1 on the apoptotic potential of reovirus is 70 related to the function of µ1 as part of incoming viral capsid. However, this idea has not directly 71 been tested. 72
Depending on the cell type, reovirus can elicit another form of regulated cell death 73 called necroptosis (15, 16) . Unlike apoptosis, necroptosis is thought to be an inflammatory form 74 of cell death (17). Reovirus-induced necroptosis is initiated by sensing of incoming genomic 75 dsRNA by RIG-I-like-receptors (RLRs) retinoic acid-inducible gene I (RIG-I) and melanoma 76 differentiation-associated protein 5 (MDA5) (16). RLRs signal via the mitochondrial antiviral 77 signaling protein (MAVS), to produce type 1 interferon (IFN). In addition to IFN signaling, de 78 novo synthesis of viral dsRNA genome is required for induction of necroptosis (16, 18) . 79
Together, these events in reovirus infection lead to receptor interacting protein 1 (RIP1) and 80 RIP3 dependent cell death (15, 16). The necroptotic effector protein mixed linkage kinase like 81 protein (MLKL) is also activated at times that are consistent with the induction of cell death (16). 82
Our working hypothesis is that de novo synthesized genomic RNA or its products are detected 83 by an IFN-stimulated gene (ISG) to induce necroptosis. Viral factors that increase dsRNA 84 synthesis or control the exposure of dsRNA are likely to influence necroptosis. However, no 85 such factors have yet been identified. 86
We sought to identify viral factors that contribute to the induction of cell death following 87 reovirus infection. Given the previously described role of µ1 in cell death, we aimed to further 88 dissect the mechanisms by which µ1 is involved in reovirus-induced cell death. Here, we 89 explored the role of newly synthesized µ1 in cell death by using siRNA mediated knockdown. 90
We observed that knockdown of µ1 does not impact apoptosis induction by reovirus suggesting 91 that µ1 present in the incoming capsid is sufficient to regulate apoptosis. In contrast, knockdown 92 of µ1 accelerates necroptosis induction following reovirus infection, indicating that newly 93 synthesized µ1 impacts this form of cell death. Furthermore, we discovered that knockdown of 94 the µ1 protein in infected cells results in an increased accumulation of progeny dsRNA, 95 secondary transcripts produced from dsRNA, and viral proteins in the infected cells. These data 96 highlight a new function for newly synthesized µ1 in controlling the levels of viral gene products 97 in infected cells and support the model that viral components that are synthesized late in 98 infection are detected to elicit necroptotic cell death. 99
100

MATERIALS AND METHODS 101
Cells. L929 cells obtained from ATCC were maintained in Eagle's MEM (Lonza) supplemented 102 to contain 5% fetal bovine serum (FBS) (Life Technologies), and 2 mM L-glutamine (Invitrogen). 103
Spinner-adapted Murine L929 cells were maintained in Joklik's MEM (Lonza) supplemented to 104 contain 5% fetal bovine serum (FBS) (Sigma-Aldrich), 2 mM L-glutamine (Invitrogen), 100 U/ml 105 penicillin (Invitrogen), 100 µg/ml streptomycin (Invitrogen), and 25 ng/ml amphotericin B (Sigma-106 Aldrich). Spinner-adapted L929 cells were used for cultivating, purifying and titering viruses. 107
HeLa cells obtained from Melanie Marketon's lab at Indiana University were maintained in 108
Dulbecco's MEM (Lonza) supplemented to 5% FBS (Sigma-Aldrich, and 2mM L-glutamine 109 (Invitrogen). 110
When needed, DMSO, Ribavirin, GuHCl, Z-VAD-FMK, Q-VD-OPh, or anti-IFNAR Ab were 143 added to the media immediately after the 1 h adsorption period. For preparation of whole cell 144 lysates, cells were washed in phosphate-buffered saline (PBS) and lysed with 1X RIPA (50 mM 145
Tris [pH 7.5], 50 mM NaCl, 1% TX-100, 1% DOC, 0.1% SDS, and 1 mM EDTA) containing a 146 protease inhibitor cocktail (Roche) and 2 mM PMSF, followed by centrifugation at 15000 × g for 147 
Quantitation of cell death by Acridine orange-ethidium bromide (AOEB) staining. ATCC 161
L929 cells (2x10 5 ) grown in 96 well-plates were adsorbed with the indicated MOI of reovirus at 162 room temperature for 1 h. The percentage of dead cells at the indicated time following infection 163 was determined using AOEB staining as described previously (6). For each experiment, >200 164 cells were counted, and the percentage of isolated cells exhibiting orange staining (EB 165 positivity) was determined by epi-illumination fluorescence microscopy using a fluorescein filter 166 set on an Olympus IX71 microscope. 167 168 Assessment of viral growth. L929 cells in 96-well plates were adsorbed in triplicate infections 169 with 2 PFU/cell of T3D for 1 h. Cells were washed once with PBS and incubated in 170 supplemented EMEM at 37°C for 24 h. Twice, the cells were frozen at -80°C and then thawed 171 prior to determination of viral titer by plaque assay. Viral yields were calculated according to the 172 following formula: log10yield24h = log10(PFU/ml)24h -log10(PFU/ml)0h. 173 174 Plaque assays. Plaque assays to determine infectivity were performed as previously described 175 with some modifications (21, 22). Briefly, control or heat-treated virus samples were diluted into 176 PBS supplemented with 2 mM MgCl2 (PBS Mg ). L cell monolayers in 6-well plates (Greiner Bio-177 One) were infected with 100 μl of diluted virus for 1 h at room temperature. Following the viral 178 attachment incubation, the monolayers were overlaid with 4 ml of serum-free medium 199 179 (Sigma-Aldrich) supplemented with 1% Bacto Agar (BD Biosciences), 10 μg/ml TLCK-treated 180 chymotrypsin (Worthington, Biochemical), 2 mM L-glutamine (Invitrogen), 100 U/ml penicillin 181 (Invitrogen), 100 μg/ml streptomycin (Invitrogen), and 25 ng/ml amphotericin B (Sigma-Aldrich). 182
The infected cells were incubated at 37°C, and plaques were counted 5 d post infection. 183 184 Assessment of caspase-3/7 activity. ATCC L929 cells (1 × 10 4 ) were siRNA transfected as 185 described above and seeded into black clear-bottom 96-well plates. 24 h following transfection, 186 cells were adsorbed with 10 PFU/cell of reovirus in serum-free medium at room temperature for 187 1 h. Following incubation of cells at 37°C for 48 h, caspase-3/7 activity was quantified using the 188 Caspase-Glo-3/7 assay system (Promega). Luminescence was quantified using plate reader 189 Synergy H1 Hybrid Reader (BioTek). increase in viral gene expression = 2 -[(T3D S1 CT -GAPDH CT)µ1 siRNA -(T3D S1 CT -GAPDH CT)control siRNA] ; (iii) 202 ratio of plus strand RNA to minus strand RNA = 2 -[(T3D S1 CT -GAPDH CT)plus strand RNA -(T3D S1 CT -GAPDH 203 CT)minus strand RNA] ; (iv) Relative levels of RNA following treatment with GuHCl = 2 -[(T3D S1 CT -GAPDH 204 CT)15-50 mM GuHCl -(T3D S1 CT -GAPDH CT)0 mM GuHCl])
. 205 206 Statistical analysis. Statistical significance between experimental groups was determined 207 using the unpaired student's t-test function in excel and graphed using Graphpad Prism 208 software. Statistical analyses for differences in gene expression by RT-qPCR were done on the 209 ΔCT values.
RESULTS 211 212
Newly synthesized µ1 does not impact reovirus-induced apoptosis. The reovirus outer 213 capsid protein µ1 regulates apoptotic cell death following infection (9-13, 24). However, whether 214 this is a function of incoming capsid-associated µ1 or newly synthesized µ1 protein has not 215 directly been evaluated. To determine if newly synthesized µ1 is responsible for this described 216 role in apoptosis, we knocked down the levels of the T3D µ1 protein in reovirus infected HeLa 217 cells using siRNA. As expected, the siRNA significantly diminished levels of newly synthesized 218 µ1 in infected cells ( Figure 1A ). To assess the impact of µ1 knockdown on levels of cell death, 219
HeLa cells transfected with either control or µ1 siRNA were infected with T3D for 48 h and cell 220 death was quantified by acridine orange ethidium bromide (AOEB) staining ( Figure 1B ). We 221 observed that preventing the expression of newly synthesized µ1 did not alter levels of cell 222 death induced in HeLa cells following T3D infection. HeLa cells display markers of apoptosis 223 following reovirus infection and have previously been suggested to undergo cell death by 224 apoptosis following reovirus infection (8, 14, 25) . To confirm that cell death in HeLa cells used 225 for these experiments occurred by apoptosis, the infected cells were treated with pan-caspase 226 inhibitor Q-VD-OPh (QVD) ( Figure 1C ). Cell death in the presence control and µ1 siRNA was 227 significantly decreased by treatment with QVD ( Figure 1C ). Thus, newly synthesized µ1 does 228 not affect the efficiency of apoptotic cell death following reovirus infection. These data also 229 suggest that the previously suggested role for µ1 in apoptosis is a function of µ1 that is a To ensure that the effect of the µ1 siRNA was specific and related to its complementarity 247 to the T3D M2 gene ( Figure 3A) , we evaluated the capacity of the µ1 siRNA to affect levels of 248 µ1 from prototype strain T1L or a M2 gene reassortant T1L/T3DM2 which expresses T3D µ1 in 249 a T1L genetic background ( Figure 3B ). We observed that T3D M2 specific siRNA failed to affect 250 expression of T1L µ1 (due to sequence mismatch) but reduced µ1 expression after infection 251 with T1L/T3DM2. Thus, the µ1 siRNA we have designed specifically and efficiently diminishes 252 the level of T3D µ1 protein in infected cells. To confirm that the increased cell death phenotype 253 is specific to knocking down µ1 from T3D, we measured cell death in µ1 siRNA-treated cells 254 infected with T1L or T1L/T3DM2 ( Figure 3C ). Because T1L induces cell death less efficiently (6, 255 7, 15), T1L induced cell death was measured at a later time post infection. Regardless, µ1 256 siRNA failed to affect cell death following T1L infection. In contrast, knockdown of µ1 following 257 infection with T1L/T3DM2 demonstrated an increase in cell death similar to what was observed 258 with T3D. This suggests that the increase in cell death observed is due to the specific siRNA-259 knockdown of µ1 and not due to off target effects of µ1 siRNA on a cellular signaling pathway.
Having established the specificity of the siRNA and the enhanced cell death phenotype 261 observed, we performed the remainder of the experiments with T3D, which has been 262 predominantly used to define reovirus-driven cell death pathways. 263
To determine if µ1 knockdown is sufficient to influence virus replication, we measured 264 viral yield over a 24 h interval. Because µ1 is an essential outer capsid protein whose function is 265 required to launch infection (26), it is expected that an efficient knockdown of newly synthesized 266 µ1 would result in a decrease in production of infectious progeny. We observed that knockdown 267 of µ1 following T3D infection results in a significant (~ 1 log10) decrease in viral yield ( Figure  268 4A). Since our siRNA targets newly synthesized µ1, it would not be expected that this 269 knockdown would impact any events early in viral replication prior to gene expression. 270
Consistent with this, we found that virus attachment and disassembly of incoming particles 271 (which are derived from normal cells) are not affected in cells that express µ1 siRNA (not 272 shown). Therefore, as expected, only events in viral replication that are dependent on de novo 273 expression of µ1 impact viral yield. 274
Newly synthesized µ1 interacts with its viral binding partner, σ3 (27-29). This interaction 275 negatively impacts the function of µ1 in apoptotic cell death (12). Free σ3 promotes viral protein 276 synthesis. However, when σ3 is complexed to µ1, the protein synthesis promoting function of σ3 277 is diminished (30, 31). To determine if the increase in cell death observed following µ1 278 knockdown is due to the presence of free σ3 in cells, L929 cells transfected with control or µ1 279 siRNA, or co-transfected with µ1 and σ3 siRNA ( Figure 4B it did not influence cell death in presence of µ1 siRNA knockdown ( Figure 5B ). These data 299 suggest that following knockdown of µ1, reovirus continues to induce a non-apoptotic form of 300 cell death. To block necroptosis, we used an siRNA specific to RIP3 ( Figure 5C ). Double 301 knockdown of µ1 and RIP3 resulted in a diminishment of cell death ( Figure 5D ). Thus, even 302 following knockdown of µ1, L929 cells infected with reovirus undergo cell death via necroptosis. 303 304
Knockdown of µ1 increases reovirus-induced necroptosis downstream of IFN signaling. 305
Based on previous data from our lab, we have proposed that necroptosis following reovirus 306 infection requires expression of type I IFN and signaling via the IFNα/β receptor (IFNAR) to 307 allow expression of a yet to be identified ISG required for cell death (16). Thus, one possible 308 way in which µ1 knockdown increases cell death could be through an increase in the synthesis 309 of type I IFN or through increased signaling via the IFNAR. We quantified levels of IFNβ mRNA and ZBP1 as a representative ISG in T3D-infected cells by RT-qPCR. At 18 h following 311 infection, a similar increase in expression of IFNβ and ZBP1 mRNA was observed in control and 312 µ1 siRNA treated cells ( Figure 6A and 6B). These data suggest that enhanced induction of 313 necroptosis in reovirus infected cells with a diminished level of µ1 is not related to enhanced 314 IFNβ induction or IFNAR signaling. 315 316 Viral RNA genome and secondary transcripts accumulate following µ1 knockdown. Our 317 previous evidence indicated that in addition to IFN signaling, de novo generation of viral dsRNA 318 genome and/or a product dependent on dsRNA synthesis contributes to the induction of 319 necroptosis by reovirus (16). Thus, one way in which µ1 knockdown can result in greater cell 320 death is due to an increased accumulation of these viral components in infected cells. To 321 address this question, we measured the levels of viral minus and plus strand RNA in infected 322 cells by strand-specific reverse transcription and qPCR. We used S1 gene derived RNAs as 323 representatives for these experiments. In comparison to control siRNA treated cells, µ1 siRNA 324 treated cells contained ~4 fold more minus strand RNA at 21 h post infection ( Figure 7A ). Since 325 minus strand RNA only exists in the context of dsRNA genome during reovirus replication (32), 326 minus strand levels are indicative of the amount of genomic dsRNA. Thus, µ1 knockdown 327 increases the level of progeny dsRNA. A significantly greater (~2-3 fold) level of S1 plus strand 328 in cells was also observed in cells transfected with µ1 siRNA ( Figure 7B ). While we observed an 329 increase in accumulation of both viral minus and plus strand RNA following knockdown of µ1, 330 under both control and µ1 knockdown conditions there is a substantially larger quantity (~100 331 fold) more plus strand RNA relative to minus strand. Furthermore, there is no significant 332 difference in the levels of plus strand RNA relative to minus strand RNA when µ1 is knocked 333 down as compared to control siRNA-treated cells ( Figure 7C ).
In reovirus infected cells, plus strand RNA is present in the context of viral genomic 335 dsRNA and in the form of viral primary and secondary transcripts (33-36). Since the experiment 336 above was performed at 21 h, our plus strand measurement represents a combination of each 337 of these plus strand species. Under the conditions used, plus strand RNA of the incoming 338 genome is near the lower limit of detection of this assay and does not impact our measurement 339 (data not shown). It is expected that if plus strand RNA is quantified early in infection, it would 340 predominantly represent primary transcripts. Inclusion of GuHCl, which blocks dsRNA synthesis 341 and therefore secondary transcription (37), would further ensure that only primary transcripts 342 are present in cells. To determine whether µ1 knockdown affects primary transcription, we 343 measured viral plus strand level at 8 h post infection in the presence of GuHCl. Under these 344 conditions, the S1 plus strand accumulated to equivalent levels in control and µ1 siRNA treated 345 cells ( Figure 7D ). Because primary transcript levels are unchanged following µ1 knockdown, 346 these data suggest that the increase in plus strand RNA observed later in infection is related 347 either to an increase in viral dsRNA, secondary transcripts, or both. and a concomitant reduction in necroptotic cell death (16, 37). Because we observed a greater 358 level of dsRNA in infected cells following µ1 knockdown (Fig. 7) , we asked if the potency with 359 which GuHCl influences dsRNA synthesis is altered in the absence of µ1. We found that at 21 h 360 post infection in control siRNA treated cells, GuHCl treatment diminishes levels of the S1 minus 361 strand RNA in a dose-dependent manner. Treatment with 15 mM GuHCl was sufficient to 362 reduce levels of S1 minus strand by about 60% (Fig 8A) . In contrast, 15 mM GuHCl did not 363 affect levels of S1 minus strand RNA levels in cells transfected with µ1 siRNA. Thus, µ1 364 knockdown influences the sensitivity of genomic dsRNA synthesis to GuHCl. We also measured 365 the impact of GuHCl on the levels of viral plus strand RNA following µ1 knockdown by RT-qPCR 366 ( Figure 9B ). Similar to what was observed for minus strand RNA levels, at 21 h post infection in 367 control siRNA treated cells, GuHCl treatment reduced levels of S1 plus strand RNA in a dose-368 dependent manner under control conditions. Treatment of control siRNA-treated cells with 15 369 mM GuHCl reduced levels of S1 plus strand RNA by ~60%. In contrast, 15 mM GuHCl reduced 370 levels of S1 plus strand RNA by only ~25% following µ1 knockdown. Therefore, µ1 knockdown 371 also decreases the sensitivity of viral plus strand RNA to GuHCl. Consistent with µ1 knockdown 372 causing an increased accumulation of these viral gene products, there is significantly more 373 minus and plus strand RNA accumulated in µ1 siRNA-treated cells relative to control siRNA-374 treated cells in the presence of each concentration of GuHCl (not shown). 375
Previously, studies have only used concentrations up to 15 mM GuHCl to investigate 376 plus and minus synthesis following reovirus infection (16, 37) . Because we used a significantly 377 higher concentration of GuHCl, we sought to confirm that GuHCl does not impact primary 378 transcription. Toward this end, we quantified levels of S1 plus strand by RT-qPCR early at 6 h 379 post infection in infected cells ( Figure 9C ). Ribavirin, which potently inhibits primary rounds of 380 plus strand synthesis (43), was used as a control. As expected, ribavirin caused a near 381 complete inhibition of the synthesis of plus strand RNA. Though treatment with increasing 382 concentration of GuHCl resulted in a reduction in S1 plus strand levels, this reduction was 383 significantly modest. Even at 50 mM GuHCl, no greater than ~ 30% reduction in the levels of 384 plus strand RNA was observed. We did not directly assess how high concentration of GuHCl 385 slightly inhibits plus strand RNA synthesis early in infection. However, based on a significantly 386 greater of reduction of plus strand RNA later in infection, we conclude that GuHCl mainly 387 impacts later stages of infection that are dependent on minus strand RNA synthesis, such as 388 secondary transcription. 389
To determine if knockdown of µ1 also confers a decrease in sensitivity of cell death to 390
GuHCl, we transfected cells with either control or µ1 siRNA and infected with T3D in the 391 presence of increasing concentrations of GuHCl. At 30 h post infection, cell death was 392 quantified by AOEB staining ( Figure 9D ). Similar to the effect of GuHCl on RNA levels we 393 observed, control siRNA treated cells demonstrated a dose dependent decrease in cell death. 394 15 mM GuHCl was sufficient to reduce cell death by ~75%. In contrast, when µ1 was knocked 395 down, even a significantly higher concentration of GuHCl (50 mM) was only able to reduce cell 396 death by ~ 50%. Together, the decreased sensitivity of minus strand synthesis, secondary 397 transcription and cell death to GuHCl following µ1 knockdown suggests that the increase in cell 398 death observed may be due to an increase in one or more viral products. 399
DISCUSSION 401
In this study, we assessed the role of newly synthesized µ1 in cell death following reovirus 402 infection. We report that whereas knockdown of µ1 does not impact apoptosis induced by 403 reovirus, µ1 knockdown enhances necroptotic cell death following reovirus infection. The loss of 404 µ1 is accompanied by an increase in accumulation of viral minus strand RNA (a measure of 405 dsRNA), plus strand RNA (which are likely secondary transcripts produced from newly 406 synthesized dsRNA), and viral proteins. Moreover, cell death following µ1 knockdown was less 407 sensitive to GuHCl, an agent that blocks dsRNA synthesis. Based on these data we conclude 408 that increased accumulation of one of these viral gene products in the absence of µ1 results in 409 enhanced cell death following reovirus infection. These data raise the following three questions: 410 (i) how does µ1 knockdown affect the generation of viral gene products; (ii) how do µ1 levels 411 influence sensitivity of virus replication to GuHCl; and (iii) how does an increase in viral gene 412 products correlate with enhanced cell death by necroptosis. These issues are discussed below. 413
An intriguing observation from our experiments is the increased accumulation of viral 414
products in absence of µ1. Viral RNA is transcribed at two stages of reovirus replication: (i) 415 during entry, by cores formed from incoming viral particles to generate primary transcripts and, 416 (ii) during assembly, by progeny cores to generate secondary transcripts (33-36). 417
Transcriptional activity following entry of the virus into cells correlates with loss of the outer 418 capsid. In vitro studies demonstrate that cores, which lack µ1, and ISVP*s, which contain µ1 in 419 an altered conformation, are transcriptionally active (44-48). In contrast, virions and ISVPs, 420 which contain µ1 in its native conformation are not. When µ1 is in its native conformation, such 421 as in virions and ISVPs, λ2, a core protein that forms turrets at the 12 icosahedral vertices of the 422 virus, assumes a closed conformation (49). In contrast, λ2 assumes an open conformation in 423 cores (49, 50 ). An open conformation for λ2 correlates with transcriptional activity, potentially 424 because this allows for entry of nucleotides and the exit of viral mRNA from these turrets (49, 425 50). Structural information on λ2 in ISVP*s is lacking but because ISVP*s are capable of 426 transcription, it is likely that λ2 conformation in ISVP*s more resembles that in cores than in 427
ISVPs. How transcriptional activity of progeny cores is regulated is not understood. However, 428 based on the regulation of transcription during entry, it is reasonable to hypothesize that 429 assembly of the outer capsid comprised of µ1-σ3 heterohexamers onto progeny cores closes 430 the structure of λ2, thereby shutting off transcription. We reason that when µ1 is knocked down, 431 outer capsid assembly is rendered inefficient. Thus, an increased proportion of progeny cores 432 are capable of performing secondary rounds of transcription or that secondary transcription 433 proceeds for a more extended period ( Figure 10 ). We think that this may explain the increase in 434 viral plus strand RNA accumulation later in infection. Because the plus strand RNA can be 435 translated, we also observe an increase in the level of viral proteins. Finally, because the plus 436 strand is packaged and used as a template for minus strand synthesis, we also observe a 437 greater level of minus strand RNA in absence of µ1. We hypothesize that continued propagation 438 of this replication loop results in the accumulation of viral mRNA, protein, and minus strand RNA 439 we observed following loss of µ1. 440
In reovirus infected cells, GuHCl blocks progeny viral dsRNA synthesis (37). Because 441 secondary transcription is dependent on dsRNA synthesis, GuHCl also diminishes secondary 442 transcription. However, the viral target of GuHCl is not known and the basis for how GuHCl 443 blocks these events during reovirus replication is not understood. Since GuHCl affects the 444 synthesis of new dsRNA, it is possible that the viral target is the polymerase itself. However, 445
because GuHCl has no effect on primary rounds of transcription, this would suggest that the 446 polymerase functions differently during plus and minus strand RNA synthesis. Alternatively, 447
GuHCl may target a factor which associates with progeny cores during dsRNA synthesis. Such 448 a factor could include a viral nonstructural protein or an outer capsid protein that is known to 449 interact with progeny cores, such as µ1. We observed that in the absence of µ1, GuHCl is less 450 capable of inhibiting viral dsRNA synthesis and secondary transcription. Thus, our data support 451 the possibility that µ1 is the target of GuHCl mediated effects on viral replication. However, 452 direct evidence for this idea is thus far lacking. 453
Our previous work has demonstrated a role for newly synthesized viral dsRNA in the 454 induction of necroptosis by reovirus. Our data presented here suggest that necroptosis induction 455 may require viral dsRNA, or products dependent on its synthesis such as secondary transcripts 456 or maximal level of viral proteins (figures 7-9). Genomic dsRNA is generated within core 457 particles which are embedded in a viral factory matrix produced by viral non-structural proteins. 458
This arrangement is thought to prevent host detection of viral genomic RNA in infected cells. 459
Nonetheless, recent evidence indicates that reovirus factories can be stained by a dsRNA 460 specific antibody (51), suggesting that at least proportion of dsRNA is accessible and likely 461 available for detection. If this accessibility is altered by µ1 knockdown, it could result in 462 enhanced cell death. During primary rounds of transcription of reovirus RNA, the synthesized 463 messages are capped and utilized for translation or packaging (52, 53). However, secondary 464 transcripts, synthesized late in infection, are uncapped (36). If uncapped transcripts are the viral 465 trigger for necroptosis, it is possible that an increase in secondary transcripts produced by µ1 466 knockdown therefore increases the amount of viral signature in infected cells, thereby leading to 467 enhanced necroptosis. Nonetheless, potential cellular sensors of dsRNA or secondary 468 transcripts that contribute to cell death are yet to be identified. The loss of µ1 also results in an 469 increase in levels of other viral proteins (Figure 8) . Thus, increased levels of one or more viral 470 proteins may also result in cell death. While increase in σ3 produced by µ1 knockdown does not 471 contribute to necroptosis, the accumulation of other viral proteins may also lead to enhanced 472 necroptosis. Connecting viral components to initiate signaling that leads to necroptosis requires 473 further investigation. 474
In conclusion, this work identifies a new role for the viral protein µ1 in limiting the 475 transcriptional activity of newly synthesized cores. Furthermore, the loss of µ1-mediated 476 regulation of viral replication events late in infection results in enhanced cell death induction. 477
These intriguing data also highlight that in addition to µ1 playing an essential role in viral entry, 478 µ1 can impact two different cell death pathways. µ1 from the incoming viral capsid potentiates 479 the activation of proapoptotic signaling pathways (10, 11). In contrast, newly synthesized µ1 that 480 is generated in infected cells indirectly, by decreasing the accumulation of viral gene products, 481 diminishes the levels of necroptosis following reovirus. Reovirus is currently being tested as an 482 oncolytic agent due to its ability to preferentially replicate in, and kill, cancer cells. Thus, 483 optimizing the capacity for reovirus to induce a specific form of cell death by manipulation of the 484 properties of the µ1 protein could be highly advantageous for maximizing its oncolytic potential. 485
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Levels of accumulated T3D S1 (A) minus strand or (B and D) plus strand RNA relative to 711 primers specific to the minus strand or plus strand of the T3D S1 gene or GAPDH mRNA. 734
Fraction of accumulated T3D S1 (A) minus strand or (B and C) plus strand relative to GAPDH 735 mRNA in the presence of GuHCl or ribavirin was quantified by qPCR and comparative CT 736 analysis for three independent infections. T3D S1 accumulation in the absence of treatment was 737 infection, was reverse transcribed using primers specific to the minus strand or plus strand of the T3D S1 gene or GAPDH mRNA. Levels of accumulated T3D S1 (A) minus strand or (B and D) plus strand RNA relative to GAPDH mRNA was quantified by qPCR and comparative CT analysis. (A, B, and D) The ratio of T3D S1 RNA to GAPDH in control siRNA-treated cells was set to 1. (C) The level of plus strand relative to minus strand was quantified by qPCR and comparative CT analysis. Mean values for three independent infections are shown. Error bars indicate SD. P values were determined by student's t-test. **, p < 0.005 . Intracellular µ1 levels affect sensitivity of viral RNA synthesis and cell death to GuHCl. L929 cells were transfected with control β-gal or µ1 siRNA using INTERFERin. 24 h following transfection cells were infected with T3D at an MOI of 10 PFU/cell and processed using conditions described. (A-D) Cells were either left untreated, or 200 µM ribavirin or GuHCl at the indicated concentrations was added when infection was initiated. RNA extracted from cells harvested (A and B) 21 h or (C) 6 h following infection was reverse transcribed using primers specific to the minus strand or plus strand of the T3D S1 gene or GAPDH mRNA. Fraction of accumulated T3D S1 (A) minus strand or (B and C) plus strand relative to GAPDH mRNA in the presence of GuHCl or ribavirin was quantified by qPCR and comparative CT analysis for three independent infections. T3D S1 accumulation in the absence of treatment was set to 1 for each siR-NA-treated sample. 
